ON1231320
ON1231320 is a highly specific polo like kinase 2 (PLK2) inhibitor with an IC50 of 0.31 μM. ON1231320 blocks tumor cell cycle progression in the G2/M phase in mitosis, causing apoptotic cell death. ON1231320, an arylsulfonyl pyrido-pyrimidinone, has antitumor activity[1][2].
Product Specifications
CAS Number
1312471-39-8
UNSPSC
12352005
Target
Apoptosis; Mitosis; Polo-like Kinase (PLK)
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/on1231320.html
Purity
99.90
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C(S(=O)(C2=CC=C(F)C=C2F)=O)=CC3=CN=C(NC4=CC5=C(NC=C5)C=C4)N=C3N1C
Molecular Formula
C22H15F2N5O3S
Molecular Weight
467.45
References & Citations
[1]M V Ramana Reddy, et al. Discovery of 2- (1H-indol-5-ylamino) -6- (2,4-difluorophenylsulfonyl) -8-methylpyrido[2,3-d]pyrimidin-7 (8H) -one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2) . Bioorg Med Chem. 2016 Feb 15;24 (4) :521-44.|[2]Shashidhar S. Jatiani, et al. Abstract 643: Targeting cancer with a selective ATP-mimetic inhibitor of polo like kinase-2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PLK1; PLK2; PLK3; PLK4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680918-100 1x 100 µL
CD44 Standard (HCAM/918), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
